Infographic | February 25, 2019

How Do Experience And Capacity Impact Oral Dose Outsourcing?

Source: ISR Reports

In Q2 2018, ISR asked 44 outsourcers of oral solid dose drug product manufacturing to select from four different reasons that manufacturing may be split between in-house and external resources. The data below show how respondents rated their organization’s experience and capacity with respect to outsourcing oral solid dose products, like tablets. The majority (48%) stated their company has adequate experience but lacks manufacturing capacity.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online